<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A decrease in the number of functional insulin-producing beta-cells contributes to the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Opinions diverge regarding the relative contribution of a decrease in beta-cell mass versus an intrinsic defect in the secretory machinery </plain></SENT>
<SENT sid="2" pm="."><plain>Here we review the evidence that <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, cytokines, leptin, <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, and some <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> may contribute to the maladaptation of beta-cells </plain></SENT>
<SENT sid="3" pm="."><plain>With respect to these causal factors, we focus on Fas, the ATP-sensitive K+ channel, insulin receptor substrate 2, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, nuclear factor-kappaB, endoplasmic reticulum stress, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction as their respective mechanisms of action </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, most of these factors are involved in inflammatory processes in addition to playing a role in both the regulation of beta-cell secretory function and cell turnover </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, the mechanisms regulating beta-cell proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and function are inseparable processes </plain></SENT>
</text></document>